Literature DB >> 35447052

Novel Hendra Virus Variant Circulating in Black Flying Foxes and Grey-Headed Flying Foxes, Australia.

Alison J Peel, Claude Kwe Yinda, Edward J Annand, Adrienne S Dale, Peggy Eby, John-Sebastian Eden, Devin N Jones, Maureen K Kessler, Tamika J Lunn, Tim Pearson, Jonathan E Schulz, Ina L Smith, Vincent J Munster, Raina K Plowright.   

Abstract

A novel Hendra virus variant, genotype 2, was recently discovered in a horse that died after acute illness and in Pteropus flying fox tissues in Australia. We detected the variant in flying fox urine, the pathway relevant for spillover, supporting an expanded geographic range of Hendra virus risk to horses and humans.

Entities:  

Keywords:  Hendra virus; Pteropus; bats; emerging infections; flying foxes; henipavirus; reservoir host; viruses; zoonoses

Mesh:

Year:  2022        PMID: 35447052      PMCID: PMC9045453          DOI: 10.3201/eid2805.212338

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


Hendra virus (HeV; genus Henipavirus, family Paramyxoviridae) is a well-characterised zoonotic pathogen endemic to Pteropus spp. bats (flying foxes) in Australia. Spillover from bats to horses has been detected 63 times; 4 of 7 persons infected from horses have died (). Quantitative reverse-transcription PCR (qRT-PCR) () is a tool used for surveillance and priority disease investigation in bats and horses (,). The high specificity of assays limits detection to a narrow range of genotypic diversity, meaning that divergent variants might remain undetected (). In October 2021, spillover of a novel variant, HeV genotype 2 (HeV-g2), resulted in the death of a horse in New South Wales (NSW), Australia, farther south than HeV had previously been detected in horses (). This spillover was detected only because diagnostic assays had been recently updated after retrospective discovery of HeV-g2 in a horse that exhibited signs of HeV disease in 2015 but tested negative through routine screening at that time (). Discovery of HeV-g2 in this horse arose using broad panparamyxovirus PCRs (), followed by next-generation sequencing and virus isolation. The variant showed 84% pairwise nucleotide identity genomewide to prototype HeV (HeV-g1), and 99% similarity with partial sequences recovered from tissue samples from a grey-headed flying fox, P. poliocephalus (). Bats submitted for lyssavirus diagnostics were opportunistically screened using an updated quantitative PCR specific for HeV-g2, which resulted in additional positive detections in tissue collected from P. poliocephalus in 2019–2021 and a little red flying fox (P. scapulatus) in 2015 (). Although HeV-g1 has been detected in tissues from all 4 flying fox species in continental Australia, excretion of the virus has been confirmed only in the black flying fox (P. alecto) and the spectacled flying fox (P. conspicillatus), suggesting these species are sources of transmission to horses (,). Sequence mismatches between HeV-g1 and HeV-g2 mean that PCR assays used in previous surveillance of reservoir hosts would not have detected the novel HeV-g2. To address this gap, we used a new qRT-PCR () to screen banked flying fox urine samples collected over a large extent of space and time.

The Study

We collected pooled urine samples from plastic sheets placed underneath flying fox roosts in southeastern Queensland and mid- to north-coast NSW during December 2016–September 2020 (Figure). We placed sheets in areas of the roost where P. alecto flying foxes were roosting, although other species were often also present. We recorded the number and species of bats immediately above the sheets. We also captured individual bats in mist nests; recorded species, sex, and age class; then collected urine samples directly from each anaesthetised bat or from a urine collection bag attached to its holding bag. Shortly after collection, we placed samples into viral lysis buffer, virus transport media, or an empty cryovial and stored them at −80°C (Appendix).
Figure

Distribution of flying fox species in Australia () and sampling locations for study of HeV variant circulating in flying foxes in southeastern Queensland and mid- to north-coast New South Wales, December 2016–September 2020. A) Locations in Australia; B) locations in study area. HeV, Hendra virus; HeV-g2, HeV genotype 2.

Distribution of flying fox species in Australia () and sampling locations for study of HeV variant circulating in flying foxes in southeastern Queensland and mid- to north-coast New South Wales, December 2016–September 2020. A) Locations in Australia; B) locations in study area. HeV, Hendra virus; HeV-g2, HeV genotype 2. We used the QIAamp Viral RNA Kit using a QIAcube HT automated system (QIAGEN, https://www.qiagen.com) to extract RNA, then eluted it in 150 μL of TE buffer and first screened it for HeV-g1 using a qRT-PCR assay targeting the P gene (Table 1). We stored extracted RNA at −80°C and then screened it for HeV-g2 using the new multiplexed qRT-PCR assay, targeting the M gene with primers specific for HeV-g1 and HeV-g2 (,) (Table 1; Appendix). We used 10-fold dilutions with a known number of genome copies to construct a standard curve, calculate copy numbers/mL, and estimate limit of detection. We amplified the partial cytochrome b gene from all positive samples (,) (Table 1) and confirmed host species identity based on sequence identity across 402-bp sequences (Appendix).
Table 1

Primers and probes used in PCR for study of novel Hendra virus variant circulating in black and grey-headed flying foxes, Australia*

TargetPrimers and ProbesReference
HeV-g1 P geneF: 5′-CCCAACCAAGAAAGCAAGAGThis study
R: 5′-TTCATTCCTCGTGACAGCAC

P: 5′-TTACTGCGGAGAATGTCCAACTGAGTG

HeV-g1 M geneF: 5′-CTTCGACAAAGACGGAACCAA(2)
R: 5′ TGGCATCTTTCATGCTCCATCTCGG

P: 5′ CCAGCTCGTCGGACAAAATT

HeV-g2 M geneF: 5′ TCTCGACAAGGACGGAGCTAA(3)
R: 5′ CCGGCTCGTCGAACAAAATT

P: 5′ TGGCATCCTTCATGCTTCACCTTGG

Partial cytochrome b geneF: 5′-CGAAGCTTGATATGAAAAACCATCGTTG(10,11)

R: 5′ AACTGCAGCCCCTCAGAATGATATTTGTCCTCA

*F, forward; R, reverse; P, probe.
We screened 4,539 pooled urine samples collected from 129 underroost sampling sessions and 1,674 urine samples collected from individual bats over 39 catching sessions during July 2017–September 2020 (Appendix Tables 1, 2). Eight pooled urine samples and 2 samples from individual flying foxes tested positive for HeV-g2 (Table 2). Positive samples were from Sunnybank in Queensland and Clunes, Lismore, Dorroughby, Maclean, and Nambucca Heads in NSW.
Table 2

Details of urine samples collected from Pteropus alecto and P. poliocephalus flying foxes in underroost sampling sessions that tested positive for HeV-g2 and associated session-level prevalence for HeV-g1 and HeV-g2, Australia*

SiteDateHeV-g2
HeV-g1
Sample IDRNA copies/mL†Species recorded‡Cyt b species§
No. positive/totalPrevalence, % (95% CI)No. positive/ totalPrevalence, % (95% CI)
Clunes, NSW2019 Jul 271/362.8(0.1–16.2)0/360.0(0–12.0)ACMAC001_35_1169 Pa Pa
Maclean, NSW2018 Jul 91/362.8(0.1–16.2)0/360.0(0–12.0)ACCLU004_22_1F225 Pp Pp
Clunes, NSW2017 Aug 81/362.8(0.1–16.2)5/3613.9(5.2–30.3)ACMAC001_35_11742 Pa; 0 Pp Pa
Clunes, NSW2018 Nov 12/513.9(0.7–14.6)4/517.8(2.5–19.7)ARCLU002_14_1380 Pa; 2 PpMixed Pp/Pa
ARCLU010_22_1171 Pa; 2 Pp Pa
Lismore, NSW2017 Aug 271/482.1(0.1–12.5)21/4843.8(29.8–58.7)ARCLU010_26_17834 Pa; 0 PpNA
Nambucca Heads, NSW2018 May 202/316.5(1.1–22.8)8/3125.8(12.5–50.1)ARLIS002_55_1670 Pa; 2 Pp Pa
ARNAM005_2_1154 Pa; 0 Pp Pa
Sunnybank, QLD2018 Nov 261/362.8(0.1–16.2)1/362.8(0.1–16.2)ARNAM005_12_1381,1230 Pa; 4 Pp Pp
Dorroughby, NSW2016 Dec 161/182.5(0.01–14.7)1/182.5(0.01–14.7)ARSUN015_15_158NR Pa

*Cyt b, Cytochrome b; HeV, Hendra virus; NSW, New South Wales; Pa, P. alecto; Pp, P. poliocephalus; QLD, Queensland; NA, not available; NR, not recorded. †HeV-g2 viral copies/mL: the minimum copy number which would be expected to reliably give a positive PCR result in all replicates in the quantitative reverse transcription PCR assay (the limit of detection) was 5–10 copies per reaction (≈1,070–2,140 copies/mL). ‡For underroost samples, the number of flying foxes recorded by species (P. alecto or P. poliocephalus) at the time of sampling might not precisely reflect the proportion of urine collected from each species. §Appendix Table 3 (https://wwwnc.cdc.gov/EID/article/28/5/21-2338-App1.pdf).

*Cyt b, Cytochrome b; HeV, Hendra virus; NSW, New South Wales; Pa, P. alecto; Pp, P. poliocephalus; QLD, Queensland; NA, not available; NR, not recorded. †HeV-g2 viral copies/mL: the minimum copy number which would be expected to reliably give a positive PCR result in all replicates in the quantitative reverse transcription PCR assay (the limit of detection) was 5–10 copies per reaction (≈1,070–2,140 copies/mL). ‡For underroost samples, the number of flying foxes recorded by species (P. alecto or P. poliocephalus) at the time of sampling might not precisely reflect the proportion of urine collected from each species. §Appendix Table 3 (https://wwwnc.cdc.gov/EID/article/28/5/21-2338-App1.pdf). We detected HeV-g2 in samples collected across all seasons. Prevalence in sessions with positive detections ranged from 2.5% to 6.5% (95% CI 0.1%–22.8%). In pooled samples, HeV-g2 was only detected in sessions when HeV-g1 was also detected (HeV-g1 prevalence range 2.5%–50.1%); however, we found no statistically significant correlation between HeV-g1 and HeV-g2 prevalence (Pearson correlation analysis ρ = 0.09; p = 0.87). Most (8/10) of the HeV-g2–positive samples had low genome copies, but 2, ARSUN015_15_1 and ARLIS002_55_1, had considerably higher copy numbers (Table 2). Individual flying foxes that tested positive included a P. poliocephalus juvenile female captured in Maclean, NSW, and a P. alecto adult male captured in Clunes, NSW (Appendix Table 3). We detected HeV-g2 in pooled samples from mixed-species roosts containing P. alecto and P. poliocephalus flying foxes. Cytochrome b sequencing identified DNA from P. alecto flying foxes in 6/8 positive underroost samples and from P. poliocephalus flying foxes in 2/8 (Table 2).

Conclusions

Urine is the route of HeV excretion from flying foxes and the source of virus transmission to horses. Detecting the novel Hendra variant HeV-g2 in the urine of flying foxes helped identify its distribution range, associated host species, transmission dynamics, and spillover risk. We show evidence that P. alecto and P. poliocephalus flying foxes excrete HeV-g2 in urine and both are likely competent reservoir hosts. We did not screen urine samples from P. conspicillatus or P. scapulatus flying foxes, so the potential of these species to excrete HeV-g2 in urine remains unconfirmed. Although HeV-g1 has been detected in flying fox urine samples collected across all seasons, prevalence peaks in winter in subtropical regions (,), which is consistent with our preliminary HeV-g2 seasonality findings (5/8 detections in late May–late August) in the study area. The significantly lower prevalence of HeV-g2 than HeV-g1 could indicate actual lower prevalence in the sampled population. Alternatively, repeated freeze-thaw cycles in our samples or the bias toward collecting P. alecto urine in our sampling design might have led to lower detection. Tissue samples from flying foxes submitted for lyssavirus testing after contact with humans or pets showed higher HeV-g2 prevalence than our samples from wild populations (), which might reflect higher prevalence in sick or stressed bats or geographical differences. HeV-g2 was previously detected in tissue samples from South Australia (3 positives from 4 samples), Victoria (7/64), and Western Australia (1/2) (). Our findings extend the known distributional range of HeV-g2 to southeastern Queensland and mid- to north-coast NSW, areas proximate to the 2 known cases of HeV-g2 spillover to horses (,). Our findings support expanding the expected geographic risk area for HeV spillover to include the distribution of P. poliocephalus flying foxes. Screening flying fox urine samples from a broader geographic range, including regions where P. alecto flying foxes are absent, should better inform epidemiologic relationships and relative prevalence of HeV variants. Given that data on the true diversity of HeV and related viruses in flying fox populations are incomplete, unbiased or Paramyxoviridae family–level viral surveillance in reservoir and spillover hosts might identify further variants. Developing a panel of diagnostic tools to detect a more comprehensive range of the viruses capable of spillover would substantially advance our ability to forecast spillover risk, manage biosecurity, and provide guidance to horse owners, veterinarians, and other stakeholders.

Appendix

Additional information on novel Hendra virus variant circulating in black flying foxes and grey-headed flying foxes, Australia.
  11 in total

1.  Development of a fluorogenic RT-PCR assay (TaqMan) for the detection of Hendra virus.

Authors:  I L Smith; K Halpin; D Warrilow; G A Smith
Journal:  J Virol Methods       Date:  2001-10       Impact factor: 2.014

2.  Sensitive and broadly reactive reverse transcription-PCR assays to detect novel paramyxoviruses.

Authors:  Suxiang Tong; Shur-Wern Wang Chern; Yan Li; Mark A Pallansch; Larry J Anderson
Journal:  J Clin Microbiol       Date:  2008-06-25       Impact factor: 5.948

Review 3.  Ecological dynamics of emerging bat virus spillover.

Authors:  Raina K Plowright; Peggy Eby; Peter J Hudson; Ina L Smith; David Westcott; Wayne L Bryden; Deborah Middleton; Peter A Reid; Rosemary A McFarlane; Gerardo Martin; Gary M Tabor; Lee F Skerratt; Dale L Anderson; Gary Crameri; David Quammen; David Jordan; Paul Freeman; Lin-Fa Wang; Jonathan H Epstein; Glenn A Marsh; Nina Y Kung; Hamish McCallum
Journal:  Proc Biol Sci       Date:  2015-01-07       Impact factor: 5.349

4.  Dynamics of mitochondrial DNA evolution in animals: amplification and sequencing with conserved primers.

Authors:  T D Kocher; W K Thomas; A Meyer; S V Edwards; S Pääbo; F X Villablanca; A C Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

5.  Cytochrome b gene for species identification of the conservation animals.

Authors:  H M Hsieh; H L Chiang; L C Tsai; S Y Lai; N E Huang; A Linacre; J C Lee
Journal:  Forensic Sci Int       Date:  2001-10-15       Impact factor: 2.395

6.  Novel Hendra Virus Variant Detected by Sentinel Surveillance of Horses in Australia.

Authors:  Edward J Annand; Bethany A Horsburgh; Kai Xu; Peter A Reid; Ben Poole; Maximillian C de Kantzow; Nicole Brown; Alison Tweedie; Michelle Michie; John D Grewar; Anne E Jackson; Nagendrakumar B Singanallur; Karren M Plain; Karan Kim; Mary Tachedjian; Brenda van der Heide; Sandra Crameri; David T Williams; Cristy Secombe; Eric D Laing; Spencer Sterling; Lianying Yan; Louise Jackson; Cheryl Jones; Raina K Plowright; Alison J Peel; Andrew C Breed; Ibrahim Diallo; Navneet K Dhand; Philip N Britton; Christopher C Broder; Ina Smith; John-Sebastian Eden
Journal:  Emerg Infect Dis       Date:  2022-03       Impact factor: 6.883

7.  Human Hendra virus encephalitis associated with equine outbreak, Australia, 2008.

Authors:  Elliott G Playford; Brad McCall; Greg Smith; Vicki Slinko; George Allen; Ina Smith; Frederick Moore; Carmel Taylor; Yu Hsin Kung; Hume Field
Journal:  Emerg Infect Dis       Date:  2010-02       Impact factor: 6.883

8.  Identifying Hendra virus diversity in pteropid bats.

Authors:  Ina Smith; Alice Broos; Carol de Jong; Anne Zeddeman; Craig Smith; Greg Smith; Fred Moore; Jennifer Barr; Gary Crameri; Glenn Marsh; Mary Tachedjian; Meng Yu; Yu Hsin Kung; Lin-Fa Wang; Hume Field
Journal:  PLoS One       Date:  2011-09-28       Impact factor: 3.240

9.  Spatiotemporal Aspects of Hendra Virus Infection in Pteropid Bats (Flying-Foxes) in Eastern Australia.

Authors:  Hume Field; David Jordan; Daniel Edson; Stephen Morris; Debra Melville; Kerryn Parry-Jones; Alice Broos; Anja Divljan; Lee McMichael; Rodney Davis; Nina Kung; Peter Kirkland; Craig Smith
Journal:  PLoS One       Date:  2015-12-01       Impact factor: 3.240

10.  Routes of Hendra Virus Excretion in Naturally-Infected Flying-Foxes: Implications for Viral Transmission and Spillover Risk.

Authors:  Daniel Edson; Hume Field; Lee McMichael; Miranda Vidgen; Lauren Goldspink; Alice Broos; Deb Melville; Joanna Kristoffersen; Carol de Jong; Amanda McLaughlin; Rodney Davis; Nina Kung; David Jordan; Peter Kirkland; Craig Smith
Journal:  PLoS One       Date:  2015-10-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.